Clinical Trials Directory

Trials / Completed

CompletedNCT03426046

Treatment of Immature Permanent Teeth With Three Different Pulp Capping Materials With Partial Pulpotomy

Partial Pulpotomy Treatment Of Immature Permanent Molars: A Randomized Clinical Trial

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
54 (actual)
Sponsor
Didem Sakaryali · Academic / Other
Sex
All
Age
6 Years – 13 Years
Healthy volunteers
Accepted

Summary

The aim of this randomized controlled trial is to compare partial pulpotomy treatments with Biodentine®, calcium hydroxide (CH) and Mineral Trioxide Aggregate (MTA) in cariously exposed asymptomatic young permanent teeth clinically and radiographically for 1 year and evaluate root developments with Image J Software Program. The null hypothesis of this study is Biodentine® will promote healing with high success rates and induce root development more than CH and MTA.

Detailed description

The purpose of this study was to evaluate clinical and radiographical success of three different materials in partial pulpotomy treatment. 50 patients with 54 asymptomatic, cariously exposed young permanent mandibular molar teeth were included to the study. The teeth were randomly divided into three main groups which were; calcium hydroxide, MTA and Biodentine® and finally restorated with stainless steel crowns. Pain, percussion sensitivity, palpation sensitivity of soft tissue around the tooth, root development, presence of lesion, integrity of lamina dura were evaluated clinically and radiographically during 12 months and recorded for each. Also, Image J Program with Turbo-Reg plug in was used for standardization of the radiographs and to determine the increase in root length.

Conditions

Interventions

TypeNameDescription
PROCEDUREPartial PulpotomyPartial removal of inflamed pulp tissue in cariously exposed teeth
DRUGPulp Capping AgentsBiocompatible materials

Timeline

Start date
2013-11-22
Primary completion
2016-04-30
Completion
2017-10-17
First posted
2018-02-08
Last updated
2018-02-12

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT03426046. Inclusion in this directory is not an endorsement.